|
ACLX
|
Arcellx, Inc.
|
US
|
NASDAQ
|
|
ALLR
|
Allarity Therapeutics, Inc.
|
US
|
NASDAQ
|
|
ANGN
|
Angion Biomedica Corp.
|
US
|
NASDAQ
|
|
BBIO
|
BridgeBio Pharma, Inc.
|
US
|
NASDAQ
|
|
BPMC
|
Blueprint Medicines Corporation
|
US
|
NASDAQ
|
|
COGT
|
Cogent Biosciences, Inc.
|
US
|
NASDAQ
|
|
CRIS
|
Curis, Inc.
|
US
|
NASDAQ
|
|
DAWN
|
Day One Biopharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
DCPH
|
Deciphera Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
EXEL
|
Exelixis, Inc.
|
US
|
NASDAQ
|
|
GTHX
|
G1 Therapeutics, Inc.
|
US
|
NASDAQ
|
|
ONTX
|
Onconova Therapeutics, Inc.
|
US
|
NASDAQ
|
|
PBYI
|
Puma Biotechnology Inc
|
US
|
NASDAQ
|
|
PRLD
|
Prelude Therapeutics Incorporated
|
US
|
NASDAQ
|
|
THRX
|
Theseus Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
ABSCF
|
Ab Science Paris
|
US
|
OTC
|
|
HMDCF
|
Hutchison China Ltd
|
US
|
OTC
|
|
0013
|
HUTCHMED China Ltd
|
HK
|
HK
|
|
2L9
|
Blueprint Medicines Corp
|
DE
|
F
|
|
2696
|
Shanghai Henlius Biotech Inc
|
HK
|
HK
|